Nectar Lifescience Faces Intense Selling Pressure Amid Consecutive Losses and New 52-Week Low
Nectar Lifescience Ltd is experiencing notable selling pressure, with the stock declining for three consecutive days and hitting a new 52-week low. Over the past month, it has dropped significantly, underperforming the Sensex, which has remained relatively stable during the same period.
Nectar Lifescience Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has recorded consecutive losses over the past three days, with a total decline of 6.69%. Today, the stock fell by 4.68%, underperforming the Sensex, which gained 0.48%. Over the past week, Nectar Lifescience has seen a decline of 7.25%, while the Sensex remained relatively stable with a 0.12% increase. The stock's performance has been particularly poor over the past month, down 31.94%, compared to the Sensex's modest decline of 2.93%. Year-to-date, Nectar Lifescience has plummeted by 60.28%, contrasting sharply with the Sensex's gain of 3.65%.
The stock has hit a new 52-week low of Rs. 15.49 today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This persistent selling trend may be attributed to various factors, including market sentiment and company-specific challenges, contributing to the stock's underperformance relative to the broader market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
